Status:
COMPLETED
Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
Lead Sponsor:
Boston University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Stress Disorders, Post-Traumatic
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare two treatments for post-traumatic stress disorder (PTSD): fluoxetine (an antidepressant) and Eye Movement Desensitization and Reprocessing (EMDR, a psychologica...
Detailed Description
To compare the short-term and long-term efficacy of two different treatment approaches in widespread use in clinical settings for treating patients with post-traumatic stress disorder (PTSD): fluoxeti...
Eligibility Criteria
Inclusion Criteria:
-
Patients must have:
Post-Traumatic Stress Disorder (PTSD).
Key Trial Info
Start Date :
January 1 1999
Trial Type :
INTERVENTIONAL
End Date :
December 1 2003
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000379
Start Date
January 1 1999
End Date
December 1 2003
Last Update
February 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Trauma Center
Brookline, Massachusetts, United States, 02446